Ernexa Therapeutics Inc. (ERNA) vs Pulmatrix, Inc. (PULM)

Ernexa Therapeutics Inc. and Pulmatrix, Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and Pulmatrix, Inc. are of similar size ($6.1M and $5.9M). Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −78.6%. Across the 13 metrics below, Pulmatrix, Inc. leads on 10 and Ernexa Therapeutics Inc. on 3.

Valuation

Metric ERNA PULM Biotechnology median
P/E n/m n/m 7.88
P/S 7.01 0.76 11.47
P/B 1.28 3.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 55.39 1.50 10.73
Earnings yield (415.94%) (67.48%) (28.84%)
Free cash flow yield (217.53%) (72.37%) (23.03%)

Profitability

Metric ERNA PULM Biotechnology median
Gross margin 83.51% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (111.99%) (57.72%)
Return on assets (176.62%) (85.74%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ERNA PULM Biotechnology median
Revenue growth (TTM) (78.60%) 6.96% 5.64%
EPS growth (last fiscal year) 95.42% 46.18% —
Revenue growth, 5-year CAGR (50.61%) (0.26%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 4.70 4.73
Net debt to EBITDA 0.21 0.79 0.96

Dividend

Metric ERNA PULM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ERNA PULM Biotechnology median
Market cap 5.91m 6.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack